TARDBP and lung carcinoma: The decreased expression of miR-500a-3p has been associated with poor survival in lung cancer patients, suggesting that TARDBP may exert an inhibitory effect on cancer by regulating miR-500a-3p.[33] NCBP2, also known as CBC2 (nuclear cap binding protein subunit 2), is a nuclear cap-binding protein complex component.